[Fundamental and clinical evaluation of a HBsAg-IgM complex radioimmunoassay kit]. 1986

I Kanamori, and S Nakano, and T Yabashi, and H Yoshida, and C Higuchi, and M Yanase, and H Iwata, and A Kawase, and Y Hattori, and Y Yamada

UI MeSH Term Description Entries
D007075 Immunoglobulin M A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin. Gamma Globulin, 19S,IgM,IgM Antibody,IgM1,IgM2,19S Gamma Globulin,Antibody, IgM
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D011933 Reagent Kits, Diagnostic Commercially prepared reagent sets, with accessory devices, containing all of the major components and literature necessary to perform one or more designated diagnostic tests or procedures. They may be for laboratory or personal use. Diagnostic Reagent Kits,Diagnostic Reagents and Test Kits,Diagnostic Test Kits,In Vitro Diagnostic Device,In Vitro Diagnostic Devices,In Vitro Diagnostic Medical Device,In Vitro Diagnostic Medical Devices,Kits, Diagnostic Reagent,Diagnostic Reagent Kit,Diagnostic Test Kit,Kit, Diagnostic Reagent,Kit, Diagnostic Test,Kits, Diagnostic Test,Reagent Kit, Diagnostic,Test Kit, Diagnostic,Test Kits, Diagnostic
D002353 Carrier State The condition of harboring an infective organism without manifesting symptoms of infection. The organism must be readily transmissible to another susceptible host. Asymptomatic Carrier State,Asymptomatic Infection Carrier,Inapparent Infection Carrier,Presymptomatic Carrier State,Presymptomatic Infection Carrier,Super-spreader Carrier,Superspreader Carrier,Asymptomatic Carrier States,Asymptomatic Infection Carriers,Carrier State, Asymptomatic,Carrier State, Presymptomatic,Carrier States,Carrier, Super-spreader,Carrier, Superspreader,Carriers, Super-spreader,Carriers, Superspreader,Inapparent Infection Carriers,Infection Carrier, Asymptomatic,Infection Carrier, Inapparent,Infection Carrier, Presymptomatic,Presymptomatic Carrier States,Presymptomatic Infection Carriers,Super spreader Carrier,Super-spreader Carriers,Superspreader Carriers
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006514 Hepatitis B Surface Antigens Those hepatitis B antigens found on the surface of the Dane particle and on the 20 nm spherical and tubular particles. Several subspecificities of the surface antigen are known. These were formerly called the Australia antigen. Australia Antigen,HBsAg,Hepatitis B Surface Antigen,Antigen, Australia
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000936 Antigen-Antibody Complex The complex formed by the binding of antigen and antibody molecules. The deposition of large antigen-antibody complexes leading to tissue damage causes IMMUNE COMPLEX DISEASES. Immune Complex,Antigen-Antibody Complexes,Immune Complexes,Antigen Antibody Complex,Antigen Antibody Complexes,Complex, Antigen-Antibody,Complex, Immune,Complexes, Antigen-Antibody,Complexes, Immune

Related Publications

I Kanamori, and S Nakano, and T Yabashi, and H Yoshida, and C Higuchi, and M Yanase, and H Iwata, and A Kawase, and Y Hattori, and Y Yamada
December 1984, Radioisotopes,
I Kanamori, and S Nakano, and T Yabashi, and H Yoshida, and C Higuchi, and M Yanase, and H Iwata, and A Kawase, and Y Hattori, and Y Yamada
December 1984, Radioisotopes,
I Kanamori, and S Nakano, and T Yabashi, and H Yoshida, and C Higuchi, and M Yanase, and H Iwata, and A Kawase, and Y Hattori, and Y Yamada
July 1982, Horumon to rinsho. Clinical endocrinology,
I Kanamori, and S Nakano, and T Yabashi, and H Yoshida, and C Higuchi, and M Yanase, and H Iwata, and A Kawase, and Y Hattori, and Y Yamada
July 1980, Horumon to rinsho. Clinical endocrinology,
I Kanamori, and S Nakano, and T Yabashi, and H Yoshida, and C Higuchi, and M Yanase, and H Iwata, and A Kawase, and Y Hattori, and Y Yamada
November 1979, Horumon to rinsho. Clinical endocrinology,
I Kanamori, and S Nakano, and T Yabashi, and H Yoshida, and C Higuchi, and M Yanase, and H Iwata, and A Kawase, and Y Hattori, and Y Yamada
December 1980, Kaku igaku. The Japanese journal of nuclear medicine,
I Kanamori, and S Nakano, and T Yabashi, and H Yoshida, and C Higuchi, and M Yanase, and H Iwata, and A Kawase, and Y Hattori, and Y Yamada
November 1979, Horumon to rinsho. Clinical endocrinology,
I Kanamori, and S Nakano, and T Yabashi, and H Yoshida, and C Higuchi, and M Yanase, and H Iwata, and A Kawase, and Y Hattori, and Y Yamada
April 1981, Horumon to rinsho. Clinical endocrinology,
I Kanamori, and S Nakano, and T Yabashi, and H Yoshida, and C Higuchi, and M Yanase, and H Iwata, and A Kawase, and Y Hattori, and Y Yamada
October 1979, Horumon to rinsho. Clinical endocrinology,
I Kanamori, and S Nakano, and T Yabashi, and H Yoshida, and C Higuchi, and M Yanase, and H Iwata, and A Kawase, and Y Hattori, and Y Yamada
October 1980, Horumon to rinsho. Clinical endocrinology,
Copied contents to your clipboard!